Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage

Abstract

Pediatric Blood & CancerVolume 61, Issue 3 p. 570-571 Letter to the Editor Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage P.J. Larcombe MD, P.J. Larcombe MD Paediatric Intensive Care Unit, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorN. Kapur MD, N. Kapur MD Department of Respiratory Medicine, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorC.J. Fraser MD, C.J. Fraser MD Department of Oncology, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorM.G. Coulthard MD, PhD, M.G. Coulthard MD, PhD Paediatric Intensive Care Unit, Royal Children‘s Hospital Brisbane, Herston, Queensland, Australia Discipline of Paediatrics and Child Health, School of Medicine, University of Queensland, Herston, Queensland, Australia Queensland Children's Medical Research Institute, Royal Children's Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorL.J. Schlapbach MD, Corresponding Author L.J. Schlapbach MD Paediatric Critical Care Research Group, Mater Children‘s Hospital Brisbane, Herston, Queensland, Australia Paediatric Intensive Care Unit, University Children's Hospital Bern, Bern, Switzerland Correspondence to: Luregn J. Schlapbach, FCICM Paediatric Critical Care Research Group, Paediatric Intensive Care Unit, Mater Children's Hospital 550, Stanley Street, South Brisbane, QLD 4101, Australia. E-mail: [email protected]Search for more papers by this author P.J. Larcombe MD, P.J. Larcombe MD Paediatric Intensive Care Unit, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorN. Kapur MD, N. Kapur MD Department of Respiratory Medicine, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorC.J. Fraser MD, C.J. Fraser MD Department of Oncology, Royal Children‘s Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorM.G. Coulthard MD, PhD, M.G. Coulthard MD, PhD Paediatric Intensive Care Unit, Royal Children‘s Hospital Brisbane, Herston, Queensland, Australia Discipline of Paediatrics and Child Health, School of Medicine, University of Queensland, Herston, Queensland, Australia Queensland Children's Medical Research Institute, Royal Children's Hospital Brisbane, Herston, Queensland, AustraliaSearch for more papers by this authorL.J. Schlapbach MD, Corresponding Author L.J. Schlapbach MD Paediatric Critical Care Research Group, Mater Children‘s Hospital Brisbane, Herston, Queensland, Australia Paediatric Intensive Care Unit, University Children's Hospital Bern, Bern, Switzerland Correspondence to: Luregn J. Schlapbach, FCICM Paediatric Critical Care Research Group, Paediatric Intensive Care Unit, Mater Children's Hospital 550, Stanley Street, South Brisbane, QLD 4101, Australia. E-mail: [email protected]Search for more papers by this author First published: 05 November 2013 https://doi.org/10.1002/pbc.24841Citations: 4 The present letter has been reviewed and approved by the Human Research Ethics Committee of the Royal Children's Hospital Brisbane, Herston, Australia. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume61, Issue3March 2014Pages 570-571 RelatedInformation